omega-n-methylarginine has been researched along with Polycystic Ovarian Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Hassany, L; Boersma, E; Danser, AHJ; Fauser, BCJM; Laven, JSE; Linstra, KM; Maassen Van Den Brink, A; Meun, C; Terwindt, GM; van den Berg, J; Wermer, MJH | 1 |
| Atkinson, G; Aziz, NF; Cable, NT; Cuthbertson, DJ; Daousi, C; Green, DJ; Jones, H; Kemp, GJ; Pugh, CJ; Sprung, VS | 1 |
1 trial(s) available for omega-n-methylarginine and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training.
Topics: Adult; Case-Control Studies; Enzyme Inhibitors; Exercise; Exercise Therapy; Female; Heart Diseases; Heart Function Tests; Hot Temperature; Humans; Insulin Resistance; Laser-Doppler Flowmetry; Lipoproteins, LDL; Microdialysis; Microvessels; Nitric Oxide; omega-N-Methylarginine; Polycystic Ovary Syndrome; Regional Blood Flow; Skin; Vasodilation | 2013 |
1 other study(ies) available for omega-n-methylarginine and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Decreased role of neuropeptides in the microvascular function in migraine patients with polycystic ovary syndrome.
Topics: Female; Humans; Middle Aged; Migraine Disorders; omega-N-Methylarginine; Polycystic Ovary Syndrome; Risk Factors; Vasodilation | 2023 |